Submitted by Anonymous (not verified) on 19 August 2026 - 10:17
Human medicines European public assessment report (EPAR): Febuxostat Viatris (previously Febuxostat Mylan), febuxostat, Date of authorisation: 15/06/2017, Revision: 16, Status: Authorised
Source: